AstraZeneca lupus drug meets main goal in study

AstraZeneca Plc said on Thursday its experimental drug to treat moderate-to-severe lupus, anifrolumab, met its main goal in a late-stage study.


from Reuters: Health News https://ift.tt/2ZsGnII

Comments

Popular posts from this blog

Man hit with $650K medical bill for emergency back surgery gets relief